Anavex Life Sciences Corp. (Nasdaq: AVXL) reported positive preclinical data for ANAVEX 2-73 to treat Parkinson's disease in mice sending the stock price up 67 cents to close at $3.28.
Anavex Life Sciences reports upbeat data
September 22, 2016 at 18:07 PM EDT
